Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China · Delayed Price · Currency is CNY 14.42
+0.17 (1.19%)
Feb 3, 2026, 3:00 PM CST
SHA:600557 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 281.38 | 391.86 | 464.16 | 434.47 | 320.54 | 262.92 |
Depreciation & Amortization | 196.38 | 196.38 | 194.88 | 189.83 | 187 | 159.58 |
Other Amortization | 8.38 | 8.38 | 5.71 | 3.65 | 4.08 | 1.12 |
Loss (Gain) From Sale of Assets | -0.7 | -0.7 | -0.76 | -1.38 | -0.97 | 0.3 |
Asset Writedown & Restructuring Costs | 1.81 | 1.81 | 2.65 | 0.53 | 2.81 | 0.23 |
Loss (Gain) From Sale of Investments | -20.9 | -20.9 | -14.79 | -4.2 | -4.06 | -2.71 |
Provision & Write-off of Bad Debts | -3.25 | -3.25 | 0.12 | 2.07 | -0.64 | 1.16 |
Other Operating Activities | -80.46 | 31.96 | 5.18 | 8.74 | 13.56 | 31.72 |
Change in Accounts Receivable | 426.77 | 426.77 | 412.01 | -37.18 | 360.36 | 486.19 |
Change in Inventory | -210.9 | -210.9 | -11.65 | -4.22 | 39.92 | -99.21 |
Change in Accounts Payable | -116.94 | -116.94 | -54.92 | 402.82 | -15.23 | -139.22 |
Operating Cash Flow | 479.57 | 702.49 | 972.32 | 995.94 | 908.3 | 701.1 |
Operating Cash Flow Growth | -37.52% | -27.75% | -2.37% | 9.65% | 29.55% | -24.26% |
Capital Expenditures | -500.78 | -476.69 | -311.29 | -211.09 | -171.52 | -190.32 |
Sale of Property, Plant & Equipment | 2.03 | 9.18 | 2.07 | 21.92 | 29.23 | 0.4 |
Divestitures | - | 10.25 | - | - | - | - |
Investment in Securities | 470.41 | 420 | -260.45 | 21.07 | -158.5 | 99.42 |
Other Investing Activities | 15.57 | 22.56 | 14.8 | 4.16 | 4.04 | 17.57 |
Investing Cash Flow | -12.77 | -14.69 | -554.88 | -163.94 | -296.76 | -72.92 |
Short-Term Debt Issued | - | - | - | - | 392 | 944.5 |
Total Debt Issued | - | - | - | - | 392 | 944.5 |
Short-Term Debt Repaid | - | - | - | -234.5 | -645.5 | -1,142 |
Total Debt Repaid | - | - | - | -234.5 | -645.5 | -1,142 |
Net Debt Issued (Repaid) | - | - | - | -234.5 | -253.5 | -197 |
Issuance of Common Stock | - | - | 4.86 | 64.7 | - | - |
Repurchase of Common Stock | - | - | - | - | -180 | - |
Common Dividends Paid | - | -213.58 | -128.51 | -2.49 | -11.05 | -68.42 |
Other Financing Activities | -132.21 | -288.54 | 75.36 | 4 | 1.64 | -2.19 |
Financing Cash Flow | -132.21 | -502.12 | -48.29 | -168.29 | -442.91 | -267.61 |
Foreign Exchange Rate Adjustments | 0 | 0.15 | 0.06 | 0.15 | - | - |
Net Cash Flow | 334.6 | 185.82 | 369.21 | 663.86 | 168.63 | 360.57 |
Free Cash Flow | -21.21 | 225.8 | 661.03 | 784.85 | 736.77 | 510.78 |
Free Cash Flow Growth | - | -65.84% | -15.78% | 6.53% | 44.24% | 17.24% |
Free Cash Flow Margin | -0.68% | 5.79% | 13.59% | 18.04% | 20.19% | 16.85% |
Free Cash Flow Per Share | -0.04 | 0.39 | 1.14 | 1.35 | 1.29 | 0.85 |
Cash Income Tax Paid | 303.21 | 416.7 | 577.46 | 516.83 | 361.61 | 429.43 |
Levered Free Cash Flow | 478.1 | 173.3 | 714.46 | 595.54 | 574.57 | 536.36 |
Unlevered Free Cash Flow | 485.56 | 187.23 | 728.51 | 596.74 | 581.54 | 551.03 |
Change in Working Capital | 96.95 | 96.95 | 315.17 | 362.23 | 385.97 | 246.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.